Microbix Biosystems to Present at Healthcare Conference
Company Announcements

Microbix Biosystems to Present at Healthcare Conference

Microbix Biosystms (TSE:MBX) has released an update.

Microbix Biosystems Inc., a life sciences company specializing in biological products for human health, is set to present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto. The event, scheduled for April 16 and 17, 2024, will see Microbix’s CEO deliver a presentation aimed at connecting with investors from Canada, the U.S., and internationally. Microbix, known for its diagnostic assay ingredients and quality assessment products, seeks to further its reach in the healthcare and life sciences sectors.

For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskMicrobix Enhances HPV Testing with New Validation
TipRanks Canadian Auto-Generated NewsdeskMicrobix Unveils Novel HSV Diagnosis Enhancement
TipRanks Canadian Auto-Generated NewsdeskMicrobix Secures Key EU Accreditations for QAPs
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App